Options for Navigating Talking About Risk and Adolescent Choices (ON-TRAC)

December 30, 2024 updated by: Rhode Island Hospital

Emotion Regulation Intervention to Prevent Substance Use Among Youth in the Child Welfare System

This study will examine the effectiveness of ON-TRAC (Options for Navigating Talking about Risk and Adolescent Choices), which is an online substance use prevention program that also teaches emotion regulation skills. 200 adolescents, 12-15 years of age, will be randomized to ON-TRAC or a wait list comparison group (who will be offered the intervention at the end of their study participation) to determine impact on substance use, emotion regulation abilities, mental health symptoms, and other risk behavior outcomes.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Contact with the Rhode Island child welfare system
  • Caregiver who is a parent/guardian of a child who experienced maltreatment
  • Caregiver who speaks English or Spanish
  • Caregiver who does not have developmental delays
  • Adolescent who is between 12-15 years of age
  • Adolescent who is fluent in English
  • Adolescent who has active follow-up with the Rhode Island child welfare system due to an indicated finding of abuse or neglect in the past year

Exclusion Criteria:

  • Adolescent who cannot read at a 4th grade level
  • Adolescent who has a sibling who has participated in the program
  • Adolescent who has developmental delays
  • Adolescent who lacks parental consent for the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ON-TRAC Intervention
Web-based emotion regulation and substance use intervention
Online tablet-based intervention that teaches youth emotion regulation skills and integrates substance use prevention content
No Intervention: Waitlist Control
Control participants are assessed on the same schedule as the treatment condition and offered the intervention after the 8-month follow-up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timeline Follow Back
Time Frame: Baseline, 2-, 5-, and 8-months
A calendar assisted daily substance use estimation method obtained by interview. Days used will serve as primary outcome. More days used represent more substance use.
Baseline, 2-, 5-, and 8-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drinking Refusal Self-Efficacy Questionnaire - Shortened Adolescent Version
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses self-efficacy to resist alcohol use. Scores range from 9 to 54. Higher scores represent greater drinking refusal self-efficacy.
Baseline, 2-, 5-, and 8-months
Drinking Refusal Self-Efficacy Questionnaire - Shortened Adolescent Version (Adapted for Marijuana Use)
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses self-efficacy to resist marijuana use. Scores range from 9 to 54. Higher scores represent greater marijuana refusal self-efficacy.
Baseline, 2-, 5-, and 8-months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth Risk Behavior Surveillance Survey
Time Frame: Baseline, 2-, 5-, and 8-months
Single items assess other risk behaviors such as sexual risk or violence behaviors. Endorsement of each individual item indicates engagement in the risk behavior.
Baseline, 2-, 5-, and 8-months
Patient-Reported Outcome Measures Information System - Anger Scale
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses symptoms of mental health and social functioning. Scores range from 5 to 25. Higher scores indicate greater anger.
Baseline, 2-, 5-, and 8-months
Difficulties in Emotion Regulation Scale
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses perceptions of emotion regulation skills. Scores range from 18-90. Higher scores indicate more difficulty regulating emotions.
Baseline, 2-, 5-, and 8-months
Emotion Regulation Behaviors Scale
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses use of emotion regulation behaviors taught in the intervention. Scores range from 9 to 36. Higher scores indicate more frequent use of the strategies taught.
Baseline, 2-, 5-, and 8-months
Diagnostic Analysis of Nonverbal Accuracy-2
Time Frame: Baseline, 2-, and 8-months
Computer-based measure that asks participants to identify the emotion of facial expressions displayed in photographs. Scores range from 0 to 20. Higher scores indicate better identification of emotions.
Baseline, 2-, and 8-months
Behavioral Indicator of Resiliency to Distress
Time Frame: Baseline, 2-, and 8-months
Computerized frustration task in which participants are given the option to quit at any time. Scores range from 0 to 300 seconds. Higher scores indicate more persistence in a frustrating task.
Baseline, 2-, and 8-months
Self-Efficacy Questionnaire for Children
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses perception of ability to cope with negative emotions. Scores range from 8 to 40. Higher scores indicate greater perceived ability to cope with negative emotions.
Baseline, 2-, 5-, and 8-months
Implicit Theories of Emotions for Children - Self subscale
Time Frame: Baseline, 2-, 5-, and 8-months
Assesses beliefs about the controllability of emotions. Scores range from 6 to 36. Higher scores indicate stronger beliefs about the controllability of emotions.
Baseline, 2-, 5-, and 8-months
Respiratory sinus arrhythmia
Time Frame: Baseline and 2-month follow up
Collected in response to virtual reality scenes, RSA is a physiological marker of emotion regulation processes calculated from heart rate variability as an index of parasympathetic activity.
Baseline and 2-month follow up
Feasibility and Acceptability Scale
Time Frame: 2-month follow-up (ON-TRAC group only)
Assesses acceptability of digital interventions to assess implementation outcomes. Scores range from 5 to 25. Higher scores indicate greater acceptability of the intervention.
2-month follow-up (ON-TRAC group only)
System Usability Scale
Time Frame: 2-month follow-up (ON-TRAC group only)
Assesses usability of technology programs to assess implementation outcomes. Scores range from 10 to 50. Higher scores indicate greater usability of the intervention.
2-month follow-up (ON-TRAC group only)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

February 1, 2029

Study Registration Dates

First Submitted

December 23, 2024

First Submitted That Met QC Criteria

December 30, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 30, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ON-TRAC (unknown Protocol ID)
  • R61DA059785 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on ON-TRAC

Subscribe